• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Preclinical IBD: One more piece of the puzzle.

作者信息

Agrawal Manasi, Torres Joana

机构信息

Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.

出版信息

United European Gastroenterol J. 2023 Feb;11(1):5-6. doi: 10.1002/ueg2.12358. Epub 2023 Jan 17.

DOI:10.1002/ueg2.12358
PMID:36650633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9892439/
Abstract
摘要

相似文献

1
Preclinical IBD: One more piece of the puzzle.临床前炎症性肠病：拼图的又一块碎片。
United European Gastroenterol J. 2023 Feb;11(1):5-6. doi: 10.1002/ueg2.12358. Epub 2023 Jan 17.
2
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease.亚临床肠道炎症会增加炎症性肠病诊断前的医疗资源利用和类固醇使用。
United European Gastroenterol J. 2023 Feb;11(1):9-18. doi: 10.1002/ueg2.12352. Epub 2022 Dec 22.
3
Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities.炎症性肠病的临床前疾病与预防策略：观点、挑战与机遇
Gut. 2016 Jul;65(7):1061-9. doi: 10.1136/gutjnl-2016-311785. Epub 2016 May 3.
4
[Pregnancy and inflammatory bowel disease].[妊娠与炎症性肠病]
Internist (Berl). 2011 Jan;52(1):76, 78-80. doi: 10.1007/s00108-010-2654-x.
5
Inflammatory bowel diseases in the elderly.老年人的炎症性肠病
Clin Geriatr Med. 2007 Nov;23(4):809-21, vi. doi: 10.1016/j.cger.2007.06.007.
6
Unmet Healthcare Needs Among People with Inflammatory Bowel Disease: A Canadian Cross-Sectional Population-Representative Study.炎症性肠病患者未满足的医疗需求：一项加拿大横断面人群代表性研究。
Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-09015-w.
7
Oral manifestations of inflammatory bowel disease: the neglected piece of the puzzle.炎症性肠病的口腔表现：被忽视的谜题。
Eur J Gastroenterol Hepatol. 2020 Nov;32(11):1422-1431. doi: 10.1097/MEG.0000000000001918.
8
Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review.亚洲人、西班牙裔和非裔美国人炎症性肠病的分布与表现：一项系统综述
Am J Gastroenterol. 2009 Aug;104(8):2100-9. doi: 10.1038/ajg.2009.190. Epub 2009 May 26.
9
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) survey.炎症性肠病治疗医师对肝功能检查结果改变的态度：一项意大利炎症性肠病研究小组（IG-IBD）的调查。
Eur J Gastroenterol Hepatol. 2025 Aug 1;37(8):930-934. doi: 10.1097/MEG.0000000000003016. Epub 2025 Jun 18.
10
Inflammatory Bowel Disease in Children and Adolescents.儿童和青少年炎症性肠病
Adv Pediatr. 2021 Aug;68:121-142. doi: 10.1016/j.yapd.2021.05.005. Epub 2021 Jun 17.

本文引用的文献

1
Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study.炎症性肠病诊断前5年的生化指标、医疗资源及药物使用趋势：一项健康维护组织队列研究
Dig Dis Sci. 2023 Feb;68(2):414-422. doi: 10.1007/s10620-022-07714-2. Epub 2022 Oct 11.
2
Immune-mediated inflammation across disease boundaries: breaking down research silos.跨疾病界限的免疫介导炎症：打破研究壁垒。
Nat Immunol. 2021 Nov;22(11):1344-1348. doi: 10.1038/s41590-021-01044-7.
3
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel Disease.ECCO 第七届科学研讨会成果：炎症性肠病的精准医学——预测和预防。
J Crohns Colitis. 2021 Sep 25;15(9):1443-1454. doi: 10.1093/ecco-jcc/jjab048.
4
Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.肠道通透性增加与克罗恩病的后期发展有关。
Gastroenterology. 2020 Dec;159(6):2092-2100.e5. doi: 10.1053/j.gastro.2020.08.005. Epub 2020 Aug 10.
5
Prevalence and duration of gastrointestinal symptoms before diagnosis of Inflammatory Bowel Disease and predictors of timely specialist review: a population-based study.炎症性肠病诊断前胃肠道症状的患病率、持续时间及及时接受专科评估的预测因素：一项基于人群的研究
J Crohns Colitis. 2020 Jul 15. doi: 10.1093/ecco-jcc/jjaa146.
6
Early microscopic findings in preclinical inflammatory bowel disease.临床前炎症性肠病的早期显微镜发现。
Dig Liver Dis. 2020 Dec;52(12):1467-1472. doi: 10.1016/j.dld.2020.05.052. Epub 2020 Jun 26.
7
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.血清生物标志物可在诊断前 5 年内识别出将要患上炎症性肠病的患者。
Gastroenterology. 2020 Jul;159(1):96-104. doi: 10.1053/j.gastro.2020.03.007. Epub 2020 Mar 9.
8
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.类风湿关节炎前临床阶段用阿巴西普预防关节炎（APIPPRA 研究）：一项多中心、随机、双盲、平行分组、安慰剂对照临床试验方案。
Trials. 2019 Jul 15;20(1):429. doi: 10.1186/s13063-019-3403-7.
9
Characteristics and Progression of Preclinical Inflammatory Bowel Disease.临床前炎症性肠病的特征和进展。
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1459-1466. doi: 10.1016/j.cgh.2017.11.006. Epub 2017 Nov 11.
10
Preventing progression from arthralgia to arthritis: targeting the right patients.预防关节痛进展为关节炎：针对合适的患者
Nat Rev Rheumatol. 2018 Jan;14(1):32-41. doi: 10.1038/nrrheum.2017.185. Epub 2017 Nov 9.